| Associations of VEGF/VEGF-Receptor and HGF/c-Met Promoter Polymorphisms With Progression/Regression of Retinopathy of Prematurity. | |
| | |
MedLine Citation:
|
PMID: 23094709 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Purpose: To determine the effect(s) of vascular endothelial growth factor (VEGF), VEGF receptor-2 (VEGFR-2), hepatocyte growth factor (HGF), and HGF receptor (c-Met) polymorphisms on progression/regression of retinopathy of prematurity (ROP) in premature infants. Materials and methods: This study comprised both a prospective analysis and a clinically relevant laboratory investigation. Enrolled were 123 Turkish preterm infants-gestational age (GA), ≤34 weeks; birth weight (BW), ≤1500 g-from a single tertiary care center. Infants were grouped as those who had undergone laser therapy (Group 1, n = 42), those with spontaneously regressed ROP (Group 2, n = 50), and those with no ROP (controls) (Group 3, n = 31). VEGF (-634) C and VEGF (-460) C polymorphisms were analyzed using the PCR-restriction fragment length polymorphism (RFLP) (PCR-RFLP) technique. VEGFR-2, HGF, and c-Met gene promoter polymorphisms were determined by direct sequencing. Results: Mean GAs and BWs of infants in Groups 1 and 2 were statistically significantly lower than those of Group 3 (p = 0.001). Frequencies of VEGF (-634) C and VEGF (-460) C polymorphisms were similar for all groups. We found a +32G→A single-nucleotide polymorphism (SNP) in the promoter region of the VEGFR-2 gene. HGF and c-Met gene promoter polymorphisms were not found in any group. Conclusions: Our results indicate that there is no association between the carrier states of gene promoter polymorphisms VEGF (-634) C, VEGF (-460) C, and VEGFR-2, and progression or spontaneous regression of ROP in preterm infants. The absence of HGF and c-Met polymorphisms in our study groups suggests that polymorphisms in the minimal promoters of these genes are not involved in the pathogenesis of ROP. |
| | |
Authors:
|
Mahmut Kaya; Murat Cokakli; Ayse Tulin Berk; Aylin Yaman; Didem Yesilirmak; Abdullah Kumral; Nese Atabey |
Related Documents
:
|
23056679 - Measurement of the urinary lactate/creatinine ratio for early diagnosis of the hypoxic-... 19731319 - Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in... 1578319 - Morphine metabolism in acutely ill preterm newborn infants. 754459 - Relationship of metabolic acidosis to urinary sodium excretion in the newborn infant. 22958509 - The step from a voluntary to a mandatory national nosocomial infection surveillance sys... 6330019 - Pharmacokinetics of cefotaxime in neonates. 22840619 - Star-crossed? the association of the 5-httlpr s allele with season of birth in a health... 9145359 - Erythromycin treatment for gastrointestinal dysmotility in preterm infants. 19637999 - Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies wit... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-10-24 |
Journal Detail:
|
Title: Current eye research Volume: - ISSN: 1460-2202 ISO Abbreviation: Curr. Eye Res. Publication Date: 2012 Oct |
Date Detail:
|
Created Date: 2012-10-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8104312 Medline TA: Curr Eye Res Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Ophthalmology, Dokuz Eylul University , Izmir , Turkey. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evaluation of Bedoradrine Sulfate (MN-221), a Novel, Highly Selective Beta(2)-Adrenergic Receptor Ag...
Next Document: Elucidating the Mechanism of Reversible Oxiranations via Magnetization Transfer Spectroscopy.